UniQure’s therapy slows Huntington’s disease progression in trial
Hailshadow | Istock | Getty Images UniQure’s experimental gene therapy for Huntington’s disease slowed progression of the mind dysfunction by 75% in an early-to-mid stage research, it stated on Wednesday.…